Frontiers in medicine · 2026
Optimizing beta-blocker therapy in cardiovascular care: a national cross-sectional assessment of physicians' and nurses' knowledge, attitudes, and practices in Saudi Arabia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alghuthmi Firas A, Haddash Ruyuf S, Alsheikh Eman O, Sannan Qusai H, Alharbi Moayed M, Alharbi Jaser F, Basranh Qusai H, Alsubhi Ahmed A, Almuzaini Ohood K, Wali Saad M
Аннотация
INTRODUCTION: Beta-blockers are a cornerstone of guideline directed medical therapy for cardiovascular diseases; however, their underutilization remains a global concern. Healthcare professionals' knowledge, attitudes, and practices play a critical role in optimizing beta-blocker prescribing and monitoring. This study aimed to assess the knowledge, attitudes, and practices of physicians and nurses regarding beta-blocker use in cardiovascular patients in Saudi Arabia.
METHODS: A national cross-sectional study was conducted among physicians and nurses working in government hospitals across Saudi Arabia. Data were collected using a structured self-administered questionnaire assessing demographics, knowledge, attitudes and practices related to beta-blocker use and monitoring. Descriptive statistics, group comparisons, and multivariable linear regression analyses were performed.
RESULTS: A total of 553 healthcare professionals participated, including 249 physicians (45.0%) and 304 nurses (55.0%). The median knowledge score was 6.0 (IQR: 5.0-8.0). Nurses demonstrated higher knowledge in titration principles (79.3% vs. 59.8%, p < 0.001) and recognition of rebound effects (74.3% vs. 65.5%, p = 0.014). In contrast, physicians showed greater knowledge in appropriate beta-blocker selection (52.2% vs. 40.8%, p = 0.008) and were more likely to correctly identify that beta-blockers are not contraindicated in all patients with diabetes (42.6% vs. 31.9%, p = 0.017). Fear of adverse effects, particularly bradycardia and hypotension, was more frequently reported among nurses (58.6% vs. 36.1%, p < 0.001). Participants with 1-5 years (β = 0.61, 95% CI: 0.14-1.07, p = 0.010) and 6-10 years (β = 0.69, 95% CI: 0.03-1.35, p = 0.040) had higher knowledge scores, while frequent patient management was associated with lower knowledge (β = -0.85, 95% CI, -1.52 to -0.18, p = 0.013). Attitude scores were lower among nurses (β = -1.28, 95% CI, -2.08 to -0.48, p = 0.002) and those managing patients less frequently (β = -1.64, 95% CI, -2.99 to -0.28, p = 0.018).
CONCLUSION: Healthcare professionals in Saudi Arabia demonstrated moderate knowledge regarding beta-blocker therapy, with distinct professional differences in knowledge domains and perceived barriers. Fear of adverse effects emerged as a key obstacle to optimal beta-blocker use, particularly among nurses. Targeted educational interventions, unified institutional protocols, and enhanced interprofessional collaboration are needed to improve adherence to guideline-directed beta-blocker therapy and optimize cardiovascular outcomes.
METHODS: A national cross-sectional study was conducted among physicians and nurses working in government hospitals across Saudi Arabia. Data were collected using a structured self-administered questionnaire assessing demographics, knowledge, attitudes and practices related to beta-blocker use and monitoring. Descriptive statistics, group comparisons, and multivariable linear regression analyses were performed.
RESULTS: A total of 553 healthcare professionals participated, including 249 physicians (45.0%) and 304 nurses (55.0%). The median knowledge score was 6.0 (IQR: 5.0-8.0). Nurses demonstrated higher knowledge in titration principles (79.3% vs. 59.8%, p < 0.001) and recognition of rebound effects (74.3% vs. 65.5%, p = 0.014). In contrast, physicians showed greater knowledge in appropriate beta-blocker selection (52.2% vs. 40.8%, p = 0.008) and were more likely to correctly identify that beta-blockers are not contraindicated in all patients with diabetes (42.6% vs. 31.9%, p = 0.017). Fear of adverse effects, particularly bradycardia and hypotension, was more frequently reported among nurses (58.6% vs. 36.1%, p < 0.001). Participants with 1-5 years (β = 0.61, 95% CI: 0.14-1.07, p = 0.010) and 6-10 years (β = 0.69, 95% CI: 0.03-1.35, p = 0.040) had higher knowledge scores, while frequent patient management was associated with lower knowledge (β = -0.85, 95% CI, -1.52 to -0.18, p = 0.013). Attitude scores were lower among nurses (β = -1.28, 95% CI, -2.08 to -0.48, p = 0.002) and those managing patients less frequently (β = -1.64, 95% CI, -2.99 to -0.28, p = 0.018).
CONCLUSION: Healthcare professionals in Saudi Arabia demonstrated moderate knowledge regarding beta-blocker therapy, with distinct professional differences in knowledge domains and perceived barriers. Fear of adverse effects emerged as a key obstacle to optimal beta-blocker use, particularly among nurses. Targeted educational interventions, unified institutional protocols, and enhanced interprofessional collaboration are needed to improve adherence to guideline-directed beta-blocker therapy and optimize cardiovascular outcomes.